Zymeworks’ mission is to make a meaningful difference in the lives of people impacted by difficult-to-treat cancers and other diseases.Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases

Core values

- **Addressing Difficult-to-Treat Diseases**: Zymeworks is developing novel, multifunctional biotherapeutics, particularly targeting HER2-expressing cancers such as biliary tract, gastric, and breast cancer, which have limited treatment options[1][4].
- **Improving Quality of Life**: The company's therapies, like zanidatamab, aim to provide new hope for patients with unresectable or metastatic HER2-positive cancers, improving their quality of life and potentially increasing life expectancy[1][4].
- **Promoting Positive Change**: Zymeworks' commitment to diversity and inclusion, as well as its initiatives to diversify clinical trials and address health disparities, contribute to positive social change[2].
- **Contributing to Community Well-being**: The company's focus on developing treatments that can reduce healthcare costs, decrease the need for costly health services, and improve patient outcomes aligns with broader community well-being goals[3].